What Researchers Did
Researchers used a mouse model of penetrating keratoplasty to investigate if depleting donor Langerhans cells with ultraviolet radiation (UVR) or hyperbaric oxygen (HBO) could improve corneal allograft survival.
What They Found
The presence of donor-derived Langerhans cells dramatically increased corneal allograft rejection from 40% to 80%. Pretreatment with either HBO or UVR sharply decreased both the incidence and tempo of rejection for grafts containing these cells. Specifically, UVR treatment abolished the immunogenicity of Langerhans cell-positive grafts.
What This Means for Canadian Patients
While conducted in mice, this research suggests that future treatments to remove specific immune cells from donor corneas could potentially reduce rejection for Canadian patients undergoing corneal transplants, especially those at high risk. This could lead to better long-term outcomes and fewer re-transplantations.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.
Study Limitations
A primary limitation is that this study was conducted in a mouse model, meaning its findings may not directly translate to human patients.